Search clinical trials for: unknown primary tumour

Total 17803 results

Aposense Ltd.

Terminated

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Metastasis to Brain of Unknown Primary
National Cancer Institute (NCI)

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Cancer

United States
National Cancer Institute (NCI)

Completed

Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma... and other conditions

United States
National Cancer Institute (NCI)

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Recurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Bladder Cancer | Stage IV Bladder Cancer | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage... and other conditions

United States
National Cancer Institute (NCI)

Completed

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Insular Thyroid Cancer | Recurrent Thyroid Cancer | Stage IIIB Non-small Cell Lung Cancer | Anaplastic Thyroid Cancer | Tongue Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous... and other conditions

United States
Sanofi

Completed

A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen (Grano-Tax)

Neoplasms (no Otherwise Specified)

South Africa
AstraZeneca

Completed

Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer

Breast Cancer

United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.
Clalit Health Services; Rosetta Genomics

Completed

Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

Neoplasms, Unknown Primary

Israel
M.D. Anderson Cancer Center
Pharmacia

Completed

Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract

Carcinoma, Neuroendocrine | Gastrointestinal Cancer

United States
M.D. Anderson Cancer Center
Sanofi-Synthelabo

Completed

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Unknown Primary Neoplasms

United States
Novartis Pharmaceuticals

Completed

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms

Netherlands, Canada, United States, Slovakia, United Kingdom
GlaxoSmithKline

Terminated

Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells

Neoplasms, Breast

Italy, United Kingdom
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Cancer

United States
Rigshospitalet, Denmark

Completed

Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

Unknown Primary Tumor

Denmark
Odense University Hospital

Unknown

CUP Project PET/CT

Metastasising Cancer of Unknown Primary

Denmark
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Brain and Central Nervous System Tumors | Carcinoma of Unknown Primary

United States
Roger Williams Medical Center
Beth Israel Deaconess Medical Center

Completed

Gene Therapy in Treating Patients With Cancer

Cancer

United States
University Hospital, Ghent

Terminated

A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis

Squamous Cell Carcinoma of the Oral Cavity | Oropharynx Metastases | Lymph Metastases

Belgium
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Cancer

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Cancer

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Cancer

United States
Hadassah Medical Organization

Unknown

Oxytocin in Cesarean Delivery

Post Partum Hemorrhage

Israel
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site

Neoplasms, Unknown Primary
Royal Adelaide Hospital

Completed

A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases

Neoplasm Metastasis | Brain Neoplasm

Australia
Mannkind Corporation

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Melanoma | Small Cell Lung Carcinoma | Gastric Cancer | Mesothelioma | Breast Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Cancer | Liver Cancer | Biliary Tract Cancer | Esophageal Carcinoma | Pancreatic Carcinoma | Gallbladder Cancer | Anal Carcinoma | Testicular Cancer | Neuroendocrine Cancer | Colore... and other conditions

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Head and Neck Cancer | Non-melanomatous Skin Cancer | Carcinoma of Unknown Primary

United States
Institut fur Diabetesforschung, Munich, Germany

Completed

Immunointervention With Calcitriol in New-Onset Type 1 Diabetes

Type 1 Diabetes

Germany
Heidelberg University
Merck KGaA, Darmstadt, Germany

Unknown

Paclitaxel/Carboplatin With or Without Cetuximab in CUP (PACET-CUP)

Carcinoma | Neoplasms, Unknown Primary

Germany
University of Michigan Rogel Cancer Center
Eli Lilly and Company

Terminated

Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

Carcinoma of Unknown Primary

United States
University of Thessaly

Unknown

Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver

Liver Cancer

Greece
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Venous Thromboembolism | Brain Tumors

United States, Canada, Australia, Italy
Eli Lilly and Company

Completed

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Adenocarcinoma

Canada
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

Carcinoma

France
National Taiwan University Hospital

Unknown

The Final Diagnosis and Treatment Result of Metastatic Cervical Carcinoma of Unknown Primary

Metastasis Cervical Lymph Nodes of Unknown Primary Carcinoma

Taiwan
KalVista Pharmaceuticals, Ltd.

Not yet recruiting

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II (KONFIDENT-KID)

Hereditary Angioedema
4C Medical Technologies, Inc.

Not yet recruiting

AltaValve Pivotal Trial

Mitral Regurgitation | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency | Mitral Incompetence
Swiss GO Trial Group
Tumor Profiler Center Switzerland

Not yet recruiting

OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy (OVPrecision)

Fallopian Tube Neoplasms | Ovarian Neoplasm Epithelial | High-grade Serous Ovarian Carcinoma (HGSOC) | Ovarian Endometrioid Carcinoma

Switzerland
Gruppo Italiano Malattie EMatologiche dell'Adulto

Not yet recruiting

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Primary Immune Thrombocytopenia
Walden Biosciences

Not yet recruiting

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Diabetic Nephropathies | Minimal Change Disease | Primary Focal Segmental Glomerulosclerosis | Primary Membranous Nephropathy | Primary Immunoglobulin A Nephropathy
Shanghai BDgene Co., Ltd.
Beijing Tongren Hospital

Recruiting

CRISPR/Cas9 Instantaneous Gene Editing Therapy to Intraocular Hypertensive POAG With MYOC Mutation

Primary Open Angle Glaucoma

China
Danderyd Hospital
University of Trieste; Istituto Auxologico Italiano

Recruiting

Mechanisms for Atrial Fibrillation in Obstructive Sleep Apnea (AF-MiTriSto)

Hypertension | Atrial Fibrillation | Obstructive Sleep Apnea | Autonomic Dysfunction | Arterial Stiffness

Sweden, Italy
First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Wenzhou Medical University; The Affiliated Hospital... and other collaborators

Recruiting

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

Multiple Myeloma | Minimal Residual Disease

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma (CD19-CARNK/T)

Mantle Cell Lymphoma (MCL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma( DLBCL)
MetaOptima Technology Inc.

Not yet recruiting

Multi-Center Study to Evaluate the Performance of DermDx for Primary Care Physicians in the Detection of Skin Cancers

Skin Cancer
Sahlgrenska University Hospital, Sweden

Recruiting

Tumour Localisation With Magnetic Clip Before Neoadjuvant Chemotherapy. (MagLocal)

Breast Conserving Surgery

Sweden
Biocodex
Exystat

Not yet recruiting

Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 (CRYSTAL)

Primary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1
Medical College of Wisconsin

Recruiting

Effects of an Air Bolus on Primary Peristalsis

Deglutition Disorders

United States
Sohag University

Recruiting

Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no Prophylactic Treatment for the Last 3 Months (rTMS)

Chronic Migraine

Egypt
Acibadem University
Boston Children's Hospital; Ege University

Recruiting

PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry

PTEN Hamartoma Tumor Syndrome | Macrocephaly Autism Syndrome

Turkey
American Hip Institute

Not yet recruiting

Peri-Operative Testosterone Administration in Primary Hip Arthroscopy

Femoro Acetabular Impingement

Search clinical trials for: unknown primary tumour

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations